(Q37950450)

25 August 2017

1 reference

title

Complete androgen blockade in prostate cancer. Organizing an overview (English)

1 reference

25 August 2017

Dalesio O

1

1 reference

PubMed ID

2203518

25 August 2017

language of work or name

English

0 references

publication date

1 September 1990

1 reference

25 August 2017

3

1 reference

inferred from page(s)

published in

Cancer

1 reference

25 August 2017

66

1 reference

25 August 2017

5 Suppl

1 reference

25 August 2017

1080-1082

1 reference

Total androgen blockade for metastatic cancer of the prostate

25 August 2017

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.1990.66.S5.1080

7 January 2021

Anandron (RU 23908) associated with orchiectomy in stage D prostate cancer. Preliminary results of a randomized, double-blind study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.1990.66.S5.1080

7 January 2021

A controlled trial of leuprolide with and without flutamide in prostatic carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.1990.66.S5.1080

7 January 2021

Effects of adjuvant tamoxifen and of cytotoxic therapy on mortality in early breast cancer. An overview of 61 randomized trials among 28,896 women.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.1990.66.S5.1080

7 January 2021

Why do we need systematic overviews of randomized trials?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.1990.66.S5.1080

7 January 2021

Avoidance of large biases and large random errors in the assessment of moderate treatment effects: the need for systematic overviews

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.1990.66.S5.1080

7 January 2021

10.1002/CNCR.1990.66.S5.1080

Identifiers

DOI

0 references

PubMed ID

2203518

1 reference

PubMed ID

2203518